Karin, Michael
Shalapour, Shabnam https://orcid.org/0000-0002-4743-3706
Article History
Received: 2 May 2021
Accepted: 2 August 2021
First Online: 31 August 2021
Competing interests
: SS declares no competing interests. MK had received research support from Jansen Pharmaceuticals, Merck and Aduro.